Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Resmed Inc
(NY:
RMD
)
216.98
-1.17 (-0.54%)
Official Closing Price
Updated: 7:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Resmed Inc
< Previous
1
2
Next >
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
April 25, 2024
From
ResMed Inc.
Via
GlobeNewswire
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
April 04, 2024
From
ResMed Inc.
Via
GlobeNewswire
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
March 15, 2024
From
ResMed Inc.
Via
GlobeNewswire
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
March 06, 2024
From
ResMed Inc.
Via
GlobeNewswire
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
February 12, 2024
From
ResMed Inc.
Via
GlobeNewswire
MatrixCare Earns Three 2024 Best in KLAS Awards
February 07, 2024
MatrixCare has been named a market leader by KLAS Research for its Home Health EHR in three Categories: Home Health – Independent – Large, Home Health – Independent – Small, and Hospice – Independent
From
MatrixCare
Via
GlobeNewswire
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
January 24, 2024
From
ResMed Inc.
Via
GlobeNewswire
HCA Healthcare Rallies: Weight-loss drugs really a big threat?
January 08, 2024
HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges.
Via
MarketBeat
Topics
ETFs
ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024
January 03, 2024
From
ResMed Inc.
Via
GlobeNewswire
ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
December 27, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices
December 20, 2023
ResMed’s masks with magnets are safe when used in accordance with the updated Instructions for Use
From
ResMed Inc.
Via
GlobeNewswire
ResMed Secures Significant Victory in Patent Fight Against New York University
December 11, 2023
From
ResMed Inc.
Via
GlobeNewswire
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
December 07, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Adopts New Operating Model to Accelerate Long-term Growth
November 09, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024
October 26, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023
October 05, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Announces Participation in Upcoming Conferences
September 05, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023
August 03, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023
July 06, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software
July 05, 2023
From
ResMed Inc.
Via
GlobeNewswire
PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP
June 08, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference
June 05, 2023
From
ResMed Inc.
Via
GlobeNewswire
3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023
May 25, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer
May 02, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2023
April 27, 2023
Year-over-year revenue grows 29%, operating profit up 28%, non-GAAP operating profit up 27%
From
ResMed Inc.
Via
GlobeNewswire
ResMed to Report Third Quarter Fiscal 2023 Earnings on April 27, 2023
April 06, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Chief Administrative Officer and Global General Counsel to Retire
March 30, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum
March 15, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep
March 13, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare Conference
March 07, 2023
From
ResMed Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.